Skip to content
Inspirata Announces Issuance of New U.S. Patent for its Digital Pathology System
Inspirata Digital Pathology Patent

Tampa, Florida, January 7, 2021 / GlobeNewswire – Cancer informatics and digital pathology provider Inspirata announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,878,025 for its Digital Pathology System. This patent joins Inspirata’s portfolio of nine awarded patents and one patent pending.

Inspirata has been a thought leader in digital pathology for more than a decade, and the Digital Pathology System patent issuance is strong evidence of Inspirata’s contribution to the foundation of the field.

“The issuance of this patent further validates our dedication and commitment to innovation and the advancement of digital pathology as a whole,” said Dr. Mark Lloyd, Executive Vice President and Founder of Inspirata. “This is an important milestone for Inspirata, and we look forward to continuing to expand our growing digital pathology portfolio.”


About Inspirata:

Inspirata, Inc. helps patients fighting cancer—and the clinicians they trust—to make every moment matter. Our comprehensive cancer informatics solutions bring disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.

Inspirata has assembled the most advanced and proven technologies to address the complex challenges of delivering cancer care and conducting ground-breaking research. We combine leading digital pathology solutions with automated cancer registry solutions, comprehensive cancer informatics and advanced patient engagement tools to bring users the broadest oncology informatics platform available globally. To learn more, visit


Inspirata Contact:

Emil Mladenov
Vice President of Corporate and Digital Marketing
Tel: +1-813-467-7616

OSF HealthCare Selects Inspirata as Its Cancer Informatics Solution Provider

OSF HealthCare Selects Inspirata as...

The new partnership between OSF HealthCare and Inspirata will see Inspirata’s data abstraction solution, E-Path Plus, implemented by OSF.
Inspirata Partners with King’s Health Partners ECMC and Guy’s and St Thomas’ NHS Foundation Trust to Evaluate the Application of AI Automation in Matching Patients with Cancer to Early Phase Clinical Trials

Inspirata Partners with King’s Health...

King’s Health Partners ECMC and Guy’s and St Thomas’ NHS Foundation Trust will pilot Inspirata's Trial Navigator™.
Inspirata Europe Achieves ISO 9001 Certification and the Inclusion of its Cancer AI on NHS Supply Chain Frameworks

Inspirata Europe Achieves ISO 9001...

Inspirata Europe has proudly achieved certification to ISO 9001 Quality Management System, Cyber Essentials, and Cyber Essential Plus.